Source:http://linkedlifedata.com/resource/pubmed/id/12585893
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-2-14
|
pubmed:abstractText |
The design and synthesis of conformationally restricted analogues of alpha-amino acids is an often used strategy in medicinal chemistry research. Here we present the rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid (1), a novel conformationally restricted (S)-glutamic acid (Glu) analogue intended as a mimic of the folded Glu conformation. The synthesis of 1 was completed in its racemic form in eight steps from commercially available starting materials. As a key step, the first facially selective hydroboration of a 5-methylidene[2.2.1]bicyclic intermediate was investigated. In this transformation, the catalytic methodology of Wilkinson's/catechol borane proved superior to stoichiometric borane or dialkyl borane reagents, in terms of higher diastereomeric excess and chemical yield. To our surprise (+/-)-1 did not show affinity in binding studies on native 2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid (AMPA) (IC(50) > 300 microM, [(3)H]AMPA) or kainic acid (IC(50) > 160 microM, [(3)H]kainic acid) receptors nor in binding studies on the cloned iGluR5,6 subtypes (IC(50) > 300 microM, [(3)H]kainic acid).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Aza Compounds,
http://linkedlifedata.com/resource/pubmed/chemical/Dicarboxylic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Glutamic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Kainic Acid,
http://linkedlifedata.com/resource/pubmed/chemical/Norbornanes,
http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Glutamate,
http://linkedlifedata.com/resource/pubmed/chemical/alpha-Amino-3-hydroxy-5-methyl-4-iso...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0022-3263
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
21
|
pubmed:volume |
68
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1489-95
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:12585893-Aza Compounds,
pubmed-meshheading:12585893-Dicarboxylic Acids,
pubmed-meshheading:12585893-Glutamic Acid,
pubmed-meshheading:12585893-Inhibitory Concentration 50,
pubmed-meshheading:12585893-Kainic Acid,
pubmed-meshheading:12585893-Magnetic Resonance Spectroscopy,
pubmed-meshheading:12585893-Molecular Conformation,
pubmed-meshheading:12585893-Molecular Mimicry,
pubmed-meshheading:12585893-Molecular Structure,
pubmed-meshheading:12585893-Norbornanes,
pubmed-meshheading:12585893-Receptors, Glutamate,
pubmed-meshheading:12585893-Stereoisomerism,
pubmed-meshheading:12585893-Structure-Activity Relationship,
pubmed-meshheading:12585893-alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid
|
pubmed:year |
2003
|
pubmed:articleTitle |
Rational design, synthesis, and pharmacological evaluation of 2-azanorbornane-3-exo,5-endo-dicarboxylic acid: a novel conformationally restricted glutamic acid analogue.
|
pubmed:affiliation |
Department of Medicinal Chemistry, The Royal Danish School of Pharmacy, Universitetsparken 2, DK-2100 Copenhagen, Denmark. lebu@dfh.dk
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|